The International Journal of Lower Extremity Wounds

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reed, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reed, J. F., III
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
The International Journal of Lower Extremity Wounds, Vol. 2, No. 3, 158-163 (2003)
DOI: 10.1177/1534734603258476

Crossover Designs in Lower Extremity Wounds

James F. Reed, III, PhD

Research Institute, St. Luke's Hospital, Bethlehem, PA

In a basic AB/BA crossover trial, patients are randomly assigned to receive either treatment A in the first period followed by treatment B in the second period, or treatment B in the first period followed by treatment A in the second period. Treatment periods are separated by a suitable washout period that is long enough for the treatment effect from the first period to have no residual effect to the second treatment period. The AB/BA crossover trial has many advantages and, when used appropriately, provides an efficient means for comparing 2 treatments. If applied and conducted inappropriately, the AB/BA crossover design has fatal flaws. The objective of this article is to introduce the AB/BA crossover trial and to present some of the issues surrounding crossover trials. The crossover trial, when properly implemented and analyzed, remains a valid and efficient design alternative to the parallel group design and should not be abandoned as has been suggested by the FDA. Crossover studies have an advantage over parallel studies, for example, elimination of between-subject variability, more statistical power because of paired comparisons, and reduced sample sizes to achieve a specified power. Although a test for carryover would be desirable, at present there is no widely recognized method for doing this, and some experts feel that no method can be reliable.

Key Words: crossover trials • carryover effect • washout period • wound healing


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?